Intellia Therapeutics, Inc.
US ˙ NasdaqGM ˙ US45826J1051

SecurityNTLA / Intellia Therapeutics, Inc.
InstitutionWalleye Capital LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Walleye Capital LLC ownership in NTLA / Intellia Therapeutics, Inc.

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 0 shares of Intellia Therapeutics, Inc. (US:NTLA) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 6,580 shares of Intellia Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (NTLA) in the form of stock options. The firm currently holds call options representing 14,300 of underlying shares valued at $183,326 USD and put options representing 2,500 of underlying shares valued at $32,050 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NTLA / Intellia Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 0 -6,580 -100.00 0 -100.00
2026-05-08 2026-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 0 -6,580 0
2026-02-13 2025-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 6,580 6,580 59 0.0002
2025-11-14 2025-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 0 -29,948 -100.00 0 -100.00
2025-08-13 2025-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 29,948 -11,524 -27.79 281 -4.76 0.0011
2025-05-14 2025-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 41,472 -142,600 -77.47 295 -86.30 0.0013
2025-02-13 2024-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 184,072 113,043 159.15 2,146 47.09 0.0052
2024-11-14 2024-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 71,029 15,874 28.78 1,460 18.23 0.0030
2024-08-14 2024-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 55,155 49,647 901.36 1,234 717.22 0.0022
2024-05-15 2024-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 5,508 -197,819 -97.29 152 -97.56 0.0003
2024-02-14 2023-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 203,327 19,872 10.83 6,199 6.88 0.0131
2023-11-21 2023-09-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 183,455 183,455 5,801 0.0148
2023-11-14 2023-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 183,455 183,455 5,801 0.0149
2023-08-14 2023-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 0 -127,504 -100.00 0 -100.00
2023-05-15 2023-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 127,504 32,080 33.62 4,752 42.75 0.0712
2023-02-14 2022-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 95,424 77,163 422.56 3,329 225.73 0.0607
2022-11-14 2022-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 18,261 18,261 1,022 0.0195
2022-08-19 2022-06-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 0 -50,521 -100.00 0 -100.00
2022-08-08 2022-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 0 -50,521 0
2022-05-27 2022-03-31 13F/A-01 INTELLIA THERAPEUTICS COM 45826J105 50,521 43,147 585.12 3,671 320.99 0.0981
2022-05-16 2022-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 50,521 43,147 3,671 0.0747
2022-05-27 2021-12-31 13F/A-01 INTELLIA THERAPEUTICS COM 45826J105 7,374 7,374 872 0.0271
2022-03-03 2021-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 7,374 7,374 872 0.0218
2020-08-14 2020-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 0 -1,485 -100.00 0 -100.00
2020-05-15 2020-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,485 -1,112 -42.82 18 -52.63 0.0040
2020-02-14 2019-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 2,597 -924 -26.24 38 -19.15 0.0025
2019-11-14 2019-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 3,521 3,521 47 0.0028
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A INTELLIA THERAPEUTICS COM Call 14,300 66.28 183 137.66 n/a n/a n/a
2026-05-08 2026-03-31 13F INTELLIA THERAPEUTICS COM Call 14,300 183 n/a n/a n/a
2026-02-13 2025-12-31 13F INTELLIA THERAPEUTICS COM Call 8,600 -96.66 77 -98.27 n/a n/a n/a
2025-11-14 2025-09-30 13F INTELLIA THERAPEUTICS COM Call 257,700 -16.11 4,450 54.46 n/a n/a n/a
2025-08-13 2025-06-30 13F INTELLIA THERAPEUTICS COM Call 307,200 708.42 2,882 967.04 n/a n/a n/a
2025-05-14 2025-03-31 13F INTELLIA THERAPEUTICS COM Call 38,000 82.69 270 11.57 n/a n/a n/a
2025-02-13 2024-12-31 13F INTELLIA THERAPEUTICS COM Call 20,800 -53.57 243 -73.70 n/a n/a n/a
2024-11-14 2024-09-30 13F INTELLIA THERAPEUTICS COM Call 44,800 99.11 921 82.90 n/a n/a n/a
2024-08-14 2024-06-30 13F INTELLIA THERAPEUTICS COM Call 22,500 40.62 504 14.32 n/a n/a n/a
2024-05-15 2024-03-31 13F INTELLIA THERAPEUTICS COM Call 16,000 -44.44 440 -49.89 n/a n/a n/a
2024-02-14 2023-12-31 13F INTELLIA THERAPEUTICS COM Call 28,800 278.95 878 265.83 n/a n/a n/a
2023-11-21 2023-09-30 13F/A INTELLIA THERAPEUTICS COM Call 7,600 -45.32 240 -57.60 n/a n/a n/a
2023-11-14 2023-09-30 13F INTELLIA THERAPEUTICS COM Call 7,600 240 n/a n/a n/a
2023-08-14 2023-06-30 13F INTELLIA THERAPEUTICS COM Call 13,900 -49.27 567 -44.56 n/a n/a n/a
2023-05-15 2023-03-31 13F INTELLIA THERAPEUTICS COM Call 27,400 -41.33 1,021 -37.32 n/a n/a n/a
2023-02-14 2022-12-31 13F INTELLIA THERAPEUTICS COM Call 46,700 436.78 1,629 234.50 n/a n/a n/a
2022-11-14 2022-09-30 13F INTELLIA THERAPEUTICS COM Call 8,700 487 n/a n/a n/a
2020-08-14 2020-06-30 13F INTELLIA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F INTELLIA THERAPEUTICS COM Call 100 -98.63 1 -99.07 n/a n/a n/a
2020-02-14 2019-12-31 13F INTELLIA THERAPEUTICS COM Call 7,300 -29.13 107 -22.46 n/a n/a n/a
2019-11-14 2019-09-30 13F INTELLIA THERAPEUTICS COM Call 10,300 -1.90 138 -19.77 n/a n/a n/a
2019-08-14 2019-06-30 13F INTELLIA THERAPEUTICS COM Call 10,500 -65.00 172 -66.41 n/a n/a n/a
2019-08-14 2019-03-31 13F/A INTELLIA THERAPEUTICS COM Call 30,000 512 n/a n/a n/a
2019-05-15 2019-03-31 13F INTELLIA THERAPEUTICS COM Call 30,000 512 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A INTELLIA THERAPEUTICS COM Put 2,500 -79.84 32 -71.17 n/a n/a n/a
2026-05-08 2026-03-31 13F INTELLIA THERAPEUTICS COM Put 2,500 32 n/a n/a n/a
2026-02-13 2025-12-31 13F INTELLIA THERAPEUTICS COM Put 12,400 -91.40 111 -95.54 n/a n/a n/a
2025-11-14 2025-09-30 13F INTELLIA THERAPEUTICS COM Put 144,200 -33.43 2,490 22.60 n/a n/a n/a
2025-08-13 2025-06-30 13F INTELLIA THERAPEUTICS COM Put 216,600 467.02 2,032 649.45 n/a n/a n/a
2025-05-14 2025-03-31 13F INTELLIA THERAPEUTICS COM Put 38,200 594.55 272 323.44 n/a n/a n/a
2025-02-13 2024-12-31 13F INTELLIA THERAPEUTICS COM Put 5,500 -94.36 64 -96.80 n/a n/a n/a
2024-11-14 2024-09-30 13F INTELLIA THERAPEUTICS COM Put 97,500 -19.82 2,004 -26.39 n/a n/a n/a
2024-08-14 2024-06-30 13F INTELLIA THERAPEUTICS COM Put 121,600 465.58 2,721 360.41 n/a n/a n/a
2024-05-15 2024-03-31 13F INTELLIA THERAPEUTICS COM Put 21,500 -16.67 591 -24.81 n/a n/a n/a
2024-02-14 2023-12-31 13F INTELLIA THERAPEUTICS COM Put 25,800 108.06 787 100.51 n/a n/a n/a
2023-11-21 2023-09-30 13F/A INTELLIA THERAPEUTICS COM Put 12,400 87.88 392 45.72 n/a n/a n/a
2023-11-14 2023-09-30 13F INTELLIA THERAPEUTICS COM Put 12,400 392 n/a n/a n/a
2023-08-14 2023-06-30 13F INTELLIA THERAPEUTICS COM Put 6,600 -8.33 269 0.37 n/a n/a n/a
2023-05-15 2023-03-31 13F INTELLIA THERAPEUTICS COM Put 7,200 242.86 268 267.12 n/a n/a n/a
2023-02-14 2022-12-31 13F INTELLIA THERAPEUTICS COM Put 2,100 -12.50 73 -45.52 n/a n/a n/a
2022-11-14 2022-09-30 13F INTELLIA THERAPEUTICS COM Put 2,400 134 n/a n/a n/a
2020-08-14 2020-06-30 13F INTELLIA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F INTELLIA THERAPEUTICS COM Put 10,200 -54.46 125 -62.01 n/a n/a n/a
2020-02-14 2019-12-31 13F INTELLIA THERAPEUTICS COM Put 22,400 94.78 329 113.64 n/a n/a n/a
2019-11-14 2019-09-30 13F INTELLIA THERAPEUTICS COM Put 11,500 -14.81 154 -30.32 n/a n/a n/a
2019-08-14 2019-06-30 13F INTELLIA THERAPEUTICS COM Put 13,500 145.45 221 135.11 n/a n/a n/a
2019-08-14 2019-03-31 13F/A INTELLIA THERAPEUTICS COM Put 5,500 94 n/a n/a n/a
2019-05-15 2019-03-31 13F INTELLIA THERAPEUTICS COM Put 5,500 94 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.